To identify other TF potentially regulating CCND2 enhancer activity in CCND2-expressing HD MM (which lack expression of MAF), we performed differential footprinting analysis in CCND2high vs CCND2low HD myeloma PC (Fig. 5g and Supplementary Fig. 6f and g). This evidence concerns the gene TF and Miyoshi myopathy.